Friday, October 20, 2023 12:30:59 PM
A composition for treating Amyotrophic Lateral Sclerosis (ALS), comprising induced placental adherent stromal cells (ASC), wherein said induced placental ASC are generated by: (i) expanding placental ASC in an expansion medium lacking
heparin and cAMP, thereby generating expanded placental ASC; and (ii) inducing said expanded placental ASC by incubating said expanded placental ASC in a bioreactor, and wherein said induced placental ASC are indicated for intrathecal administration.
https://patentscope.wipo.int/search/en/detail.jsf?docId=IL406584960&_cid=P12-LNYSXQ-76811-1
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM